Transcripts Regeneron Pharmaceuticals, Inc.
Equities
REGN
US75886F1075
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 529.24 USD | +1.42% |
|
+7.30% | -25.70% |
| 06-13 | 23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm | RE |
| 06-13 | 23Andme Reaches Agreement For Sale Of Business To TTAM Research Institute | RE |
Transcripts
Search
06-12 | ||
05-20 | ||
05-13 | ||
04-29 | ||
03-11 | ||
03-04 | ||
02-04 | ||
01-13 | ||
12-05 | ||
11-19 | ||
31/10/24 | ||
16/09/24 | ||
05/09/24 | ||
04/09/24 | ||
01/08/24 | ||
11/06/24 | ||
05/06/24 | ||
14/05/24 | ||
02/05/24 | ||
13/03/24 | ||
12/03/24 | ||
06/03/24 | ||
14/02/24 | ||
02/02/24 | ||
08/01/24 |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition